Mr Matthew Glover
Lecturer (Education) in Health Economics
Mary Seacole 2nd Floor
- Email: matthew.glover@brunel.ac.uk
- Tel: +44 (0)1895 267835
- Global Public Health
- Department of Health Sciences
- College of Health, Medicine and Life Sciences
Summary
Matt is a health economist with experience in both academia and consultancy. His role at Brunel is education focussed, where he is Programme Director of MSc Health Economics and Health Policy, a new programme which launched in 2022. He also leads teaching on the Health Economics module of the MPHHP, in addition to other commitments.
In a research capacity, he has been involved in several clinical trial study teams as part of collaborations with University of Cambridge, University of Warwick and University of Nottingham. As co-investigator, he has held grants funded by Wellcome Trust, NIHR (i4i, HTA, COVID-19) and UKRI. He has also provided input to the external assessment of industry submissions for NICE, as part of their medical technologies evaluation programme.
He currently holds a part-time Senior Research Fellow position at the University of Surrey, with current projects including EU Horizon 2020 and NIHR funded research in Diabetes (iHealth, BEATDiabetes) and care home staffing and quality (STARQ) and supports the Kent/Surrey Research Design Service.
Before these appointments he held postions as Research Assistant and Fellow in the Health Economics Research Group at Brunel and Principal Health Economist at a London based consultancy.
Qualifications
MSc Health Economics, University of York
BA (Hons), Economics, Durham University
PhD, Health Economics, Brunel University London
Newest selected publications
Bath, PM., Ball, J., Boyd, M., Gage, H., Glover, M., Godfrey, M., et al. (2022) 'Prophylactic Treatment of COVID-19 in Care Homes Trial (PROTECT-CH)'. .
Kasturiratne, A., Khawaja, KI., Ahmad, S., Siddiqui, S., Shahzad, K., Athauda, LK., et al. (2021) 'The iHealth-T2D study, prevention of type 2 diabetes amongst South Asians with central obesity and prediabetes: study protocol for a randomised controlled trial'. Trials, 22 (1). pp. 1 - 13. ISSN: 1745-6215 Open Access Link
Glover, M., Caplin, M., Leeuwenkamp, OR. and Longworth, L. (2021) 'Use of [177Lu]Lu-DOTA-TATE in the treatment of gastroenteropancreatic neuroendocrine tumours: Results of a UK cost-effectiveness modelling study'. European Journal of Cancer, Supplement, 16. pp. 14 - 23. ISSN: 1359-6349 Open Access Link
Muilwijk, M., Loh, M., Siddiqui, S., Mahmood, S., Palaniswamy, S., Shahzad, K., et al. (2021) 'Effects of a lifestyle intervention programme after 1 year of follow-up among South Asians at high risk of type 2 diabetes: a cluster randomised controlled trial'. BMJ Global Health, 6 (11). pp. 1 - 12. ISSN: 2059-7908 Open Access Link
Sweeting, MJ., Marshall, J., Glover, M., Nasim, A. and Bown, MJ. (2021) 'Evaluating the Cost-Effectiveness of Changes to the Surveillance Intervals in the UK Abdominal Aortic Aneurysm Screening Programme'. Value in Health, 24 (3). pp. 369 - 376. ISSN: 1098-3015